PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation

Sakurai, 2017, Role of insulin receptor substrates in the progression of hepatocellular carcinoma, Sci Rep, 7, 5387, 10.1038/s41598-017-03299-3 Molinaro, 2020, Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype, Sci Rep, 10, 12031, 10.1038/s41598-020-68721-9 Calle, 2004, Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms, Nat Rev Canc, 4, 579, 10.1038/nrc1408 Hassan, 2010, Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma, Cancer, 116, 1938, 10.1002/cncr.24982 Burke, 2015, Synergy in activating class I PI3Ks, Trends Biochem Sci, 40, 88, 10.1016/j.tibs.2014.12.003 Vogelstein, 2013, Cancer genome landscapes, Science, 339, 1546, 10.1126/science.1235122 Horie, 2004, Hepatocyte-specific PTEN deficiency results in steatohepatitis and hepatocellular carcinomas, J Clin Invest, 113, 1774, 10.1172/JCI20513 Dombrowski, 2006, Hepatocellular neoplasms induced by low-number pancreatic islet transplants in autoimmune diabetic BB/Pfd rats, Canc Res, 66, 1833, 10.1158/0008-5472.CAN-05-2787 Janku, 2018, Targeting the PI3K pathway in cancer: are we making headway?, Nat Rev Clin Oncol, 15, 273, 10.1038/nrclinonc.2018.28 Wang, 2016, Spontaneous hepatocellular carcinoma after the combined deletion of Akt Isoforms, Cancer Cell, 29, 523, 10.1016/j.ccell.2016.02.008 Hopkins, 2018, Suppression of insulin feedback enhances the efficacy of PI3K inhibitors, Nature, 560, 499, 10.1038/s41586-018-0343-4 Molinaro, 2019, Insulin-driven PI3K-AKT signaling in the hepatocyte is mediated by redundant PI3Kalpha and PI3Kbeta activities and is promoted by RAS, Cell Metab, 29, 10.1016/j.cmet.2019.03.010 Breasson, 2017, PI3Kgamma activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity, Sci Signal, 10, 10.1126/scisignal.aaf2969 Becattini, 2011, PI3Kgamma within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance, Proc Natl Acad Sci U S A, 108, E854, 10.1073/pnas.1106698108 Kobayashi, 2011, Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance, Proc Natl Acad Sci U S A, 108, 5753, 10.1073/pnas.1016430108 Perino, 2014, Combined inhibition of PI3Kbeta and PI3Kgamma reduces fat mass by enhancing alpha-MSH-dependent sympathetic drive, Sci Signal, 7, 10.1126/scisignal.2005485 Torres, 2019, p110gamma deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity, Proc Natl Acad Sci U S A, 116, 14724, 10.1073/pnas.1813012116 Breasson, 2018, PI3Kgamma ablation does not promote diabetes in db/db mice, but improves insulin sensitivity and reduces pancreatic beta-cell apoptosis, FASEB J, 32, 319, 10.1096/fj.201700372RR Park, 2010, Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, Cell, 140, 197, 10.1016/j.cell.2009.12.052 Wilson, 2015, NFkappaB1 is a suppressor of neutrophil-driven hepatocellular carcinoma, Nat Commun, 6, 6818, 10.1038/ncomms7818 Hirsch, 2000, Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation, Science, 287, 1049, 10.1126/science.287.5455.1049 Puri, 2005, The role of endothelial PI3Kgamma activity in neutrophil trafficking, Blood, 106, 150, 10.1182/blood-2005-01-0023 Kaneda, 2016, PI3Kgamma is a molecular switch that controls immune suppression, Nature, 539, 437, 10.1038/nature19834 Kaneda, 2016, Macrophage PI3Kgamma drives pancreatic ductal adenocarcinoma progression, Canc Discov, 6, 870, 10.1158/2159-8290.CD-15-1346 De Henau, 2016, Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells, Nature, 539, 443, 10.1038/nature20554 Arfianti, 2020, Exercise retards hepatocarcinogenesis in obese mice independently of weight control, J Hepatol, 73, 140, 10.1016/j.jhep.2020.02.006 Ko, 2018, PI3Kdelta is a therapeutic target in hepatocellular carcinoma, Hepatology, 68, 2285, 10.1002/hep.30307 Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423 D'Avola, 2016, Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease-hepatocellular carcinoma: magnitude of the problem from a hepatology clinic perspective, Clin Liver Dis (Hoboken), 8, 1004